The Philadelphia region is a major innovation center, distinguished by its strong research institutions, growing venture ecosystem, and collaborative public–private partnerships.
The only U.S. ecosystem to grow between 2020 and 2024, Philadelphia’s momentum is closely tied to its research hospitals and 120+ universities, which continually generate new ventures and produce a diverse talent pipeline of 430,000+ students. In 2025, the Philadelphia Department of Commerce partnered with Temple University to host the Startup World Cup competition, where startups received recognition and funding support.
As a top 10 global VC market, accelerators and founder development programs help transform research into venture-backed companies. In March 2026, the Science Center launched the Capital Readiness Program 10th cohort, with alumni collectively raising $137M — advancing healthcare innovation, creating jobs, and attracting investor interest from across the U.S. The Founder Institute opened applications for its Spring 2026 Philadelphia cohort, and in 2025, NJEDA and CoreWeave launched a $20M AI Hub Fund to help startups access capital and scale.
In 2025, Ben Franklin Technology Partners led the region with nine Life Science investments and 14 technology investments deploying $4.7M. Ben Franklin's GO Pennsylvania Fund II deployed an additional $7M across three investments. PROPEL, the National Center for Precision Medicine led by Ben Franklin, is a maturing EDA-designated Regional Tech Hub, bolstered by a $500,000 EDA grant — creating an ecosystem where Precision Medicine, Cell & Gene Therapy, and vaccine technologies are invented, manufactured, and commercialized.
Philadelphia continues to attract major capital, with five recent funding rounds exceeding $100M: Quavo Fraud & Disputes ($300M), Gopuff ($250M), Dispatch Bio ($216M), Impulse Dynamics ($158M), and Fore Biotherapeutics ($115.2M). In 2025, Eli Lilly announced a new Gateway Labs location in Philadelphia. Thermo Fisher Scientific opened an Advanced Therapies Collaboration Center at BioLabs Philadelphia. Merck began construction on a $1B biologics center of excellence in Wilmington, with operations expected by 2028.
Regional innovation events include BioLabs Investor Day, 1PHL Innovation Weekend, and Philly Tech Week.
Philadelphia
#33
#14
Top 10
Top 15
Top 15
Highlights
Ecosystem by the Numbers
ECOSYSTEM VALUE
ECOSYSTEM VALUE GROWTH
AI-Native Ecosystem Value
AI-Native Ecosystem Value Growth
EARLY-STAGE FUNDING GROWTH
AI-Native Early Stage Funding Growth
TOTAL VC FUNDING
TOTAL EARLY–STAGE FUNDING
EXIT AMOUNT
EXIT COUNT (#)
TIME TO EXIT
NUMBER OF UNICORNS
MEDIAN SEED ROUND
Median Series A Round
Top Funded Startups
SOFT. ENGINEER SALARY
Sub-Sector Strengths
Approximately 75% of the Philadelphia region’s R&D activity is focused on Life Sciences, supported by strong university research and a steady pipeline of venture-backed therapeutics startups. In February 2026, University City Science Center received a $300,000 grant from Roche Group member Genentech to support closing the gap between breakthrough innovation and patient impact, translating regional biomedical discoveries into startups and market-ready technologies. Philadelphia’s Department of Commerce launched an SBIR/STTR Matching Grant Program offering up to $50,000 in commercialization support. Significant funding rounds in 2026 include Alveus Therapeutics’ $160M Series A and Century Therapeutics’ $135M round.
Philadelphia is an emerging AI hub, fueled by top research institutions, rich data assets, and growing investment in applied AI. Amazon announced a $20B investment to build two AI-focused data center campuses in Pennsylvania, expanding its AI and cloud operations while creating 1,200+ jobs and boosting regional computing capacity. In October 2025, Philadelphia’s municipal government created an AI policy task force to guide responsible AI use across city departments, supporting broader efforts to integrate AI into public services. The University of Pennsylvania and Princeton University advance the region’s AI sector through research, dedicated AI programs, and industry partnerships.
Philadelphia’s Advanced Manufacturing & Robotics ecosystem continues to advance through venture funding and the commercialization of industrial robotics platforms. In August 2025, Philadelphia-based robotics platform Fort Robotics raised an $18.9M round to expand software systems that manage and secure fleets of industrial robots used by companies including Amazon, John Deere, and Boston Dynamics. In July 2025, autonomous security startup Asylon secured a $26M Series B to scale its robotics-as-a-service platform, combining drones and robotic patrol systems for enterprise and defense clients.
Selected Startup Organizations
Startup Genome Members
Ben Franklin Technology Partners of Southeastern Pennsylvania is a leading U.S. venture development organization supporting early-stage, technology-driven companies in the Philadelphia region. Through investment, business support, and ecosystem connections, it helps innovative startups launch, grow, and scale. Ranked among the most active seed and early-stage investors in the United States, the nonprofit has supported more than 2,000 companies, generating over $5 billion in economic impact and creating more than 32,000 jobs. It operates as an initiative of the Pennsylvania Department of Community and Economic Development and is funded by the Ben Franklin Technology Development Authority.
The Chamber of Commerce for Greater Philadelphia is the metro-regional chamber serving the 11-county, tri-state Greater Philadelphia area, acting as a central connector across Pennsylvania, New Jersey, and Delaware. It convenes business, government, and civic leaders to strengthen the region’s economy, attract investment, and advance inclusive growth. By aligning stakeholders around shared priorities, the Chamber helps drive coordinated regional action. Working closely with members, investors, and partners, it promotes forward-looking policies, strategic partnerships, and targeted initiatives that enhance competitiveness, support business expansion, and position Greater Philadelphia as a leading global destination for innovation, talent, and enterprise.
University City Science Center is a leading nonprofit catalyst for entrepreneurship, healthcare innovation, and economic growth in Philadelphia, with a legacy dating back to 1963. Working closely with health systems, investors, and industry leaders, the Science Center aligns capital, evidence, and partnerships to bridge high-potential companies from breakthrough to real-world impact.Recognized by The Brookings Institution as a best-in-class investor and economic development partner, it plays a pivotal role in strengthening and advancing the region’s innovation ecosystem.
News from the Ecosystem
Explore more ecosystems
Work with us
If you are interested in working with us to drive global attention to your ecosystem, please get in touch with Marina Krizman, Director of Business Development.